Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient

被引:14
作者
Dong, Ju-Qin [1 ,2 ]
Li, Man-Zhi [1 ,2 ]
Liu, Zhi-Gang [1 ,3 ]
Zhong, Qian [1 ,2 ]
Xiong, Dan [1 ,2 ]
Xu, Li-Hua [1 ,2 ]
Du, Yong [1 ,2 ]
Xia, Yun-Fei [1 ,3 ]
Zeng, Mu-Sheng [1 ,2 ]
机构
[1] State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Therapy, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Nasopharyngeal carcinoma; Epstein-Barr virus; SUNE2 cell line;
D O I
10.5732/cjc.011.10317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The undifferentiated form of nasopharyngeal carcinoma (NPC) is the most common malignant head and neck cancer in South China, especially in Cantonese populations. However, few NPC cell lines have been established from the patients in this region. In this study, we established a new NPC cell line, termed SUNE2, from a Cantonese patient with undifferentiated NPC. This cell line had extremely low concentrations of Epstein-Barr virus (EBV) DNA in long-term culture and expressed low levels of latent membrane protein 1 (LMP1), latent membrane protein 2A (LMP2A), BamH1-A right frame 1 (BARF1), EBV-encoded RNA-1 (EBER1), and EBV-encoded RNA-2 (EBER2) in early passages. SUNE2 cells also showed much stronger transforming ability than 5-8F cells in colony formation assays and anchorage-independent growth assays in soft agar, and they only need 2 weeks to form tumors in nude mice. In summary, the SUNE2 cell line is a new in vitro model that can be used for further research on the mechanisms underlying the occurrence and development of NPC.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 22 条
[1]   Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays [J].
Bell, Andrew I. ;
Groves, Katherine ;
Kelly, Gemma L. ;
Croom-Carter, Debbie ;
Hui, Edwin ;
Chan, Anthony T. C. ;
Rickinson, Alan B. .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :2885-2890
[2]   EPSTEIN-BARR-VIRUS LATENT GENE-TRANSCRIPTION IN NASOPHARYNGEAL CARCINOMA-CELLS - COEXPRESSION OF EBNA1, LMP1, AND LMP2 TRANSCRIPTS [J].
BROOKS, L ;
YAO, QY ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF VIROLOGY, 1992, 66 (05) :2689-2697
[3]   ESTABLISHMENT AND CHARACTERIZATION OF 3 TRANSPLANTABLE EBV-CONTAINING NASOPHARYNGEAL CARCINOMAS [J].
BUSSON, P ;
GANEM, G ;
FLORES, P ;
MUGNERET, F ;
CLAUSSE, B ;
CAILLOU, B ;
BRAHAM, K ;
WAKASUGI, H ;
LIPINSKI, M ;
TURSZ, T .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :599-606
[4]  
Cao Su-Mei, 2011, Chin J Cancer, V30, P114
[5]  
CHANG YS, 1989, CANCER RES, V49, P6752
[6]  
Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO
[7]  
2-F
[8]  
Chow KC, 1997, CANCER EPIDEM BIOMAR, V6, P363
[9]   Epstein-Barr virus infection. [J].
Cohen, JI .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :481-492
[10]   Epstein-Barr virus-associated epithelial and mesenchymal neoplasms [J].
Deyrup, Andrea T. .
HUMAN PATHOLOGY, 2008, 39 (04) :473-483